OA12462A - Composition pharmaceutique à base de macrolides pour application locale en ophtalmologie. - Google Patents

Composition pharmaceutique à base de macrolides pour application locale en ophtalmologie. Download PDF

Info

Publication number
OA12462A
OA12462A OA1200300246A OA1200300246A OA12462A OA 12462 A OA12462 A OA 12462A OA 1200300246 A OA1200300246 A OA 1200300246A OA 1200300246 A OA1200300246 A OA 1200300246A OA 12462 A OA12462 A OA 12462A
Authority
OA
OAPI
Prior art keywords
azithromycin
pharmaceutical composition
oily vehicle
solution
triglycerides
Prior art date
Application number
OA1200300246A
Other languages
English (en)
French (fr)
Inventor
Jacques Luyckx
Frederic Pilotaz
Original Assignee
Thea Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thea Lab filed Critical Thea Lab
Publication of OA12462A publication Critical patent/OA12462A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
OA1200300246A 2001-04-12 2002-04-11 Composition pharmaceutique à base de macrolides pour application locale en ophtalmologie. OA12462A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0105114A FR2823441B1 (fr) 2001-04-12 2001-04-12 Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation

Publications (1)

Publication Number Publication Date
OA12462A true OA12462A (fr) 2006-06-24

Family

ID=8862340

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200300246A OA12462A (fr) 2001-04-12 2002-04-11 Composition pharmaceutique à base de macrolides pour application locale en ophtalmologie.

Country Status (31)

Country Link
US (1) US7064109B2 (ko)
EP (1) EP1377316B1 (ko)
JP (2) JP4558275B2 (ko)
KR (1) KR100835002B1 (ko)
CN (1) CN1496270B (ko)
AR (1) AR034033A1 (ko)
AT (1) ATE397460T1 (ko)
BR (1) BRPI0208367B8 (ko)
CA (1) CA2443728C (ko)
CY (1) CY1108302T1 (ko)
CZ (1) CZ300213B6 (ko)
DE (1) DE60226962D1 (ko)
DK (1) DK1377316T3 (ko)
EA (1) EA008088B1 (ko)
EG (1) EG23169A (ko)
ES (1) ES2307754T3 (ko)
FR (1) FR2823441B1 (ko)
HK (1) HK1065708A1 (ko)
HR (1) HRP20030907B1 (ko)
HU (1) HU230459B1 (ko)
MA (1) MA27005A1 (ko)
MX (1) MXPA03009349A (ko)
OA (1) OA12462A (ko)
PA (1) PA8543401A1 (ko)
PE (1) PE20021082A1 (ko)
PL (1) PL204403B1 (ko)
PT (1) PT1377316E (ko)
SI (1) SI1377316T1 (ko)
TN (1) TNSN03091A1 (ko)
WO (1) WO2002083178A1 (ko)
ZA (1) ZA200307718B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2314354T3 (es) * 2004-11-09 2009-03-16 Novagali Pharma S.A. Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo.
FR2884716B1 (fr) * 2005-04-22 2009-08-21 Thea Sa Lab Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
WO2007074904A1 (ja) * 2005-12-28 2007-07-05 Wakamoto Pharmaceutical Co., Ltd. 水性医薬組成物
CA2679448A1 (en) * 2007-02-28 2008-09-04 Aciex, Inc. Methods and compositions for normalizing meibomian gland secretions
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
CN101780105B (zh) * 2009-01-20 2011-09-28 沈阳兴齐制药有限公司 小牛血去蛋白提取物的滴眼液
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
US8106111B2 (en) * 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
EP2394636B1 (en) * 2010-05-28 2014-03-19 Novagali Pharma S.A. Method for treating retinal conditions using an intraocular tamponade
US9044508B2 (en) * 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
EP3478269A4 (en) * 2016-06-29 2020-04-08 Otonomy, Inc. OTIC FORMULATIONS BASED ON TRIGLYCERIDES AND THEIR USES
DK3266446T3 (en) * 2016-07-07 2019-02-11 Salvat Lab Sa Eye preparation comprising castor oil and medium chain triglyceride

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1152644A (en) * 1966-07-01 1969-05-21 Abbott Lab Stable Solutions of Erythromycin Free Base
JPS6468328A (en) * 1987-09-09 1989-03-14 Suntory Ltd Anticorneoulcerative
JP2563336B2 (ja) * 1987-06-01 1996-12-11 エーザイ株式会社 角膜透過促進点眼剤
FR2746035B1 (fr) * 1996-03-15 1998-06-12 Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications
ATE271390T1 (de) * 1997-12-02 2004-08-15 Pfizer Prod Inc Verwendung von azithromycin zur topischen behandlung von augeninfektionen
JP2000159659A (ja) * 1998-11-30 2000-06-13 Kazuo Tsubota 眼科用人工涙液
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections

Also Published As

Publication number Publication date
CA2443728C (fr) 2011-01-04
HK1065708A1 (en) 2005-03-04
EG23169A (en) 2004-06-30
EP1377316B1 (fr) 2008-06-04
BR0208367B1 (pt) 2013-11-12
US7064109B2 (en) 2006-06-20
BR0208367A (pt) 2004-03-09
HRP20030907B1 (en) 2010-04-30
TNSN03091A1 (fr) 2005-12-23
EP1377316A1 (fr) 2004-01-07
ES2307754T3 (es) 2008-12-01
PA8543401A1 (es) 2003-01-24
ZA200307718B (en) 2004-09-02
HUP0303864A2 (hu) 2004-03-01
PE20021082A1 (es) 2002-12-18
KR100835002B1 (ko) 2008-06-09
JP2010043109A (ja) 2010-02-25
PL204403B1 (pl) 2010-01-29
WO2002083178A1 (fr) 2002-10-24
JP2004526763A (ja) 2004-09-02
JP4558275B2 (ja) 2010-10-06
CZ300213B6 (cs) 2009-03-18
CN1496270A (zh) 2004-05-12
HU230459B1 (hu) 2016-07-28
AR034033A1 (es) 2004-01-21
ATE397460T1 (de) 2008-06-15
DE60226962D1 (de) 2008-07-17
CN1496270B (zh) 2010-05-26
SI1377316T1 (sl) 2008-10-31
EA008088B1 (ru) 2007-02-27
FR2823441A1 (fr) 2002-10-18
HRP20030907A2 (en) 2004-02-29
MXPA03009349A (es) 2004-11-12
PT1377316E (pt) 2008-09-15
PL363538A1 (en) 2004-11-29
CA2443728A1 (fr) 2002-10-24
BRPI0208367B8 (pt) 2021-05-25
EA200301108A1 (ru) 2004-04-29
FR2823441B1 (fr) 2004-09-10
KR20030088466A (ko) 2003-11-19
CZ20032771A3 (cs) 2004-01-14
JP5170780B2 (ja) 2013-03-27
HUP0303864A3 (en) 2012-07-30
CY1108302T1 (el) 2014-02-12
MA27005A1 (fr) 2004-12-20
US20040197340A1 (en) 2004-10-07
DK1377316T3 (da) 2008-09-22

Similar Documents

Publication Publication Date Title
FR2588189A1 (fr) Composition pharmaceutique de type a transition de phase liquide-gel
EP1377316B1 (fr) Composition pharmaceutique a base de azalides pour application locale en ophtalmologie
LU86386A1 (fr) Nouveaux medicaments a usage topique
FR2918891A1 (fr) Solution ophtalmique a base de prostaglandines sans conservateur
LU87675A1 (fr) Nouvelles compositions pharmaceutiques a base de cyclosporines
LU87409A1 (fr) Nouvelle forme cristalline de la ciclosporine,sa preparation et les compositions pharmaceutiques la contenant
WO1998001118A1 (fr) Composition pharmaceutique pour administration par voie orale
BE1003647A5 (fr) Composition pharmaceutique de nicardipine pour administration parenterale.
LU86172A1 (fr) Composition aqueuse de cromoglycate de sodium
FR2678167A1 (fr) Preparations ophtalmiques a liberation prolongee.
EP0045338B1 (fr) Utilisation des glycosylglucanes en gastroentérologie dans le traitement des colopathies
WO2009007660A1 (fr) Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage
CA3090570A1 (fr) Composition multiusage de torasemide
CA2985014C (fr) Composition ophtalmique comprenant de l'acide lipoique et un polymere muco-mimetique
FR2503563A1 (fr) Composition pour collyre a base de sulfate de chondroitine a
EP1185255A2 (fr) Medicaments ophtalmologiques neuro-et retino-protecteurs
FR2773489A1 (fr) Nouvelle composition destinee a la voie oromuqueuse notamment pernasale
EP0433140B1 (fr) Nouvelle préparation pharmaceutique anti-allergique à action prolongée
WO2015173377A1 (fr) Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
WO2023118591A1 (fr) Composition topique et son applicateur, destines a soulager le chalazion
EP1336404A1 (fr) Composition ophtalmique sous forme d'émulsion
CA2255202A1 (fr) Utilisation de la flavine-adenine-dinucleotide pour la preparation de compositions ophtalmiques utiles pour le traitement de l'oeil sec
FR2746014A1 (fr) Composition ophtalmologique du type subissant une transition de phase liquide-gel
FR2971941A1 (fr) Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine
EP0865289A1 (fr) Compositions a base d'arctium majus